A Phase I Study of ADI-PEG 20 plus FOLFOX in Patients with Advanced Digestive Cancers | Clinical Trial
Clinical trials are research studies that evaluate the safety and effectiveness of new treatment approaches for a disease. If you are being treated for stomach cancer at Memorial Sloan Kettering, you may be offered the opportunity to take part in a clinical trial at some point during your treatment.
In some cases, a study may give you access to new therapies that are not yet readily available. Clinical trials may also be used to compare diagnostic tests, prevention strategies, or other aspects of your care.
Our clinical trials reflect the collaborative expertise of Memorial Sloan Kettering researchers and clinicians with specialties in gastrointestinal oncology, pathology, genomics, and more. We are examining the effectiveness of immunotherapy drugs, combinations of conventional chemotherapy medicines, and novel targeted therapies, among other areas. We are also investigating novel biomarkers that can help us identify new treatments for stomach cancer, as well as causes of resistance to promising targeted therapies.
We maintain a continually updated listing of stomach cancer clinical trials at Memorial Sloan Kettering that are currently enrolling new patients. To learn more about a study, choose from the list below: